[go: up one dir, main page]

FR2705097B1 - Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent. - Google Patents

Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent.

Info

Publication number
FR2705097B1
FR2705097B1 FR9305620A FR9305620A FR2705097B1 FR 2705097 B1 FR2705097 B1 FR 2705097B1 FR 9305620 A FR9305620 A FR 9305620A FR 9305620 A FR9305620 A FR 9305620A FR 2705097 B1 FR2705097 B1 FR 2705097B1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
lupane derivatives
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9305620A
Other languages
English (en)
Other versions
FR2705097A1 (fr
Inventor
Dereu Norbert
Evers Michel
Poujade Christele
Soler Francoise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9305620A priority Critical patent/FR2705097B1/fr
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to EP94915592A priority patent/EP0698016A1/fr
Priority to AU67244/94A priority patent/AU6724494A/en
Priority to CA002162703A priority patent/CA2162703A1/fr
Priority to PCT/FR1994/000533 priority patent/WO1994026725A1/fr
Priority to JP6525051A priority patent/JPH08509969A/ja
Priority to ZA943202A priority patent/ZA943202B/xx
Publication of FR2705097A1 publication Critical patent/FR2705097A1/fr
Application granted granted Critical
Publication of FR2705097B1 publication Critical patent/FR2705097B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FR9305620A 1993-05-11 1993-05-11 Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent. Expired - Lifetime FR2705097B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9305620A FR2705097B1 (fr) 1993-05-11 1993-05-11 Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent.
AU67244/94A AU6724494A (en) 1993-05-11 1994-05-06 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
CA002162703A CA2162703A1 (fr) 1993-05-11 1994-05-06 Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1994/000533 WO1994026725A1 (fr) 1993-05-11 1994-05-06 Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent
EP94915592A EP0698016A1 (fr) 1993-05-11 1994-05-06 Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent
JP6525051A JPH08509969A (ja) 1993-05-11 1994-05-06 新規ルパン誘導体、その製造およびそれを含む医薬組成物
ZA943202A ZA943202B (en) 1993-05-11 1994-05-09 Novell lupane derivatives their preparation and pharmaceutical compositions which contain them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305620A FR2705097B1 (fr) 1993-05-11 1993-05-11 Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent.

Publications (2)

Publication Number Publication Date
FR2705097A1 FR2705097A1 (fr) 1994-11-18
FR2705097B1 true FR2705097B1 (fr) 1995-08-04

Family

ID=9446987

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9305620A Expired - Lifetime FR2705097B1 (fr) 1993-05-11 1993-05-11 Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent.

Country Status (7)

Country Link
EP (1) EP0698016A1 (fr)
JP (1) JPH08509969A (fr)
AU (1) AU6724494A (fr)
CA (1) CA2162703A1 (fr)
FR (1) FR2705097B1 (fr)
WO (1) WO1994026725A1 (fr)
ZA (1) ZA943202B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869535A (en) 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
US5658947A (en) * 1995-03-21 1997-08-19 Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma using betalinic acid
US5750578A (en) * 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
EP1473301A3 (fr) * 1997-06-04 2005-01-26 Cornell Research Foundation, Inc. Derives de betulinol
US6124362A (en) 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
US6482857B1 (en) 1998-07-17 2002-11-19 The University Of Texas Southwestern Medical Center Compositions which contain triterpenes for regulating hair growth
US6369101B1 (en) 1999-02-26 2002-04-09 Regents Of The University Of Minnesota Therapeutic method to treat herpes virus infection
EP1309605A1 (fr) 2000-08-18 2003-05-14 The Board Of Trustees Of The University Of Illinois Promedicaments de derives de l'acide betulinique pour le traitement du cancer et du vih
EA200700611A1 (ru) 2004-09-10 2008-02-28 Бридж Б. Саксена Производные бетулинола в качестве противораковых агентов
JP2008543945A (ja) * 2005-06-22 2008-12-04 ミリアド ジェネティクス， インコーポレイテッド 抗ウイルス化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01143832A (ja) * 1987-12-01 1989-06-06 Toa Nenryo Kogyo Kk 制癌剤

Also Published As

Publication number Publication date
EP0698016A1 (fr) 1996-02-28
AU6724494A (en) 1994-12-12
FR2705097A1 (fr) 1994-11-18
CA2162703A1 (fr) 1994-11-24
ZA943202B (en) 1995-01-16
JPH08509969A (ja) 1996-10-22
WO1994026725A1 (fr) 1994-11-24

Similar Documents

Publication Publication Date Title
FR2683531B1 (fr) Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent.
DZ2009A1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
DZ2149A1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2676446B1 (fr) Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2727411B1 (fr) Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2697841B1 (fr) Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2708606B1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
FR2665159B1 (fr) Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2697019B1 (fr) Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2642069B1 (fr) Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
MA26455A1 (fr) Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2779724B1 (fr) Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2732968B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2712288B1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2687151B1 (fr) Nouveaux derives de la baccatine iii et de la desacetyl-10 baccatine iii, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2712289B1 (fr) Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2705671B1 (fr) Nouveaux dérivés de l'hydroxybiphényle, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2705094B1 (fr) Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2705097B1 (fr) Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2721023B1 (fr) Nouveaux Taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2732342B1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
OA09439A (fr) "Nouveaux dérivés benzoxazolinoniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent".
FR2691459B1 (fr) Nouveaux derives de la phenothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2711370B1 (fr) Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2673629B1 (fr) Nouveaux derives du benzopyrane leur procede de preparation et les compositions pharmaceutiques qui les contiennent.